[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:hamartin":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Hamartin",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06308419","A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions",[11],"Phase 1","RECRUITING","2026-08-26T02:19:22.562392Z","2026-05-05T02:43:29.070302Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT05843253","Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant",[19],"Phase 2","2026-08-26T02:19:31.671303Z","2026-05-05T02:43:29.388169Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT06160310","Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)",[],"2026-08-26T02:19:25.538428Z","2026-05-13T02:55:06.420937Z"]